Clinical Trial Update: Study Evaluating Sirolimus in the Treatment of Kidney Transplant [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sirolimus in kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Diseases
• Kidney Failure

Drugs mentioned

• Rapamune (sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Failure, Kidney Diseases | Phase 4 | Status: COMPLETED